InMed Pharmaceuticals (INM): Health and Wellness Product Launches

LONDON, UK / ACCESSWIRE / June 1, 2022 / InMed Pharmaceuticals has reported fiscal Q322 results (ending 31 March) benefiting from commercial sales into the health and wellness market. Its product launches of high-value rare cannabinoids contributed …